When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - Emergent Bio inks five-year deal with J&J for manufacture of COVID-19 vaccine
Johnson & Johnson
Emergent BioSolutions (NYSE:EBS) has closed a five-year agreement with Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceuticals for large-scale drug substance manufacturing for J&J's SARS-CoV-2 vaccine, Ad26.COV2-S.
More news on: Emergent BioSolutions Inc., Johnson & Johnson, Healthcare stocks news, Stocks on the move,